PL2248533T3 - Polipeptyd pochodzący od enterokoka i jego zastosowanie do szczepienia - Google Patents

Polipeptyd pochodzący od enterokoka i jego zastosowanie do szczepienia

Info

Publication number
PL2248533T3
PL2248533T3 PL09006113T PL09006113T PL2248533T3 PL 2248533 T3 PL2248533 T3 PL 2248533T3 PL 09006113 T PL09006113 T PL 09006113T PL 09006113 T PL09006113 T PL 09006113T PL 2248533 T3 PL2248533 T3 PL 2248533T3
Authority
PL
Poland
Prior art keywords
enterococcus
vaccination
polypeptide derived
polypeptide
derived
Prior art date
Application number
PL09006113T
Other languages
English (en)
Inventor
Johannes Hübner
Andrea Kropec-Hübner
Irina Sava
Original Assignee
Univ Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Freiburg filed Critical Univ Freiburg
Publication of PL2248533T3 publication Critical patent/PL2248533T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1228—Enterobacterales (O), e.g. Citrobacter (G), Serratia (G), Proteus (G), Providencia (G), Morganella (G) or Yersinia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PL09006113T 2009-05-05 2009-05-05 Polipeptyd pochodzący od enterokoka i jego zastosowanie do szczepienia PL2248533T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09006113.6A EP2248533B1 (en) 2009-05-05 2009-05-05 Polypeptide derived from enterococcus and its use for vaccination

Publications (1)

Publication Number Publication Date
PL2248533T3 true PL2248533T3 (pl) 2014-04-30

Family

ID=40690329

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09006113T PL2248533T3 (pl) 2009-05-05 2009-05-05 Polipeptyd pochodzący od enterokoka i jego zastosowanie do szczepienia

Country Status (8)

Country Link
US (1) US8741302B2 (pl)
EP (1) EP2248533B1 (pl)
JP (1) JP5661744B2 (pl)
CA (1) CA2760239A1 (pl)
DK (1) DK2248533T3 (pl)
ES (1) ES2444693T3 (pl)
PL (1) PL2248533T3 (pl)
WO (1) WO2010127784A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8501907B2 (en) 2007-08-10 2013-08-06 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
MX2013005646A (es) * 2010-11-19 2013-08-01 Janssen Biotech Inc Composiciones de vacuna de fragmentos de clivaje de la inmunoglobulina.
EP3415160B1 (en) * 2014-03-04 2021-08-18 Klinikum der Universität München Polypeptides derived from enterococcus and their use for vaccination and the generation of therapeutic antibodies
WO2016172476A1 (en) 2015-04-24 2016-10-27 The Rockefeller University Modified microorganisms expressing saga as anti-infective agents, probiotics and food components
US11058756B2 (en) 2017-01-19 2021-07-13 Yale University Compositions and methods of treating autoimmune disease by reducing enterococcus
EP3927358A4 (en) 2019-02-20 2022-11-09 The Rockefeller University MODIFIED MICROORGANISMS EXPRESSING SAGAS AND ASSOCIATED COMPOSITIONS FOR INFECTION IMMUNOMODULATION AND CANCER IMMUNOTHERAPY
DE102023131065A1 (de) 2023-11-09 2025-05-15 Consiglio Nazionale Delle Ricerche Hochstabile Antigen-präsentierende Fusionsproteine und deren Verwendung als Impfstoffkomponenten für die Therapie und/oder Prophylaxe von pathogenen Bakterien

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US6583275B1 (en) * 1997-07-02 2003-06-24 Genome Therapeutics Corporation Nucleic acid sequences and expression system relating to Enterococcus faecium for diagnostics and therapeutics
CA2407352A1 (en) * 2000-04-21 2001-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of acne vulgaris
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms

Also Published As

Publication number Publication date
EP2248533A1 (en) 2010-11-10
CA2760239A1 (en) 2010-11-11
ES2444693T3 (es) 2014-02-26
HK1146471A1 (en) 2011-06-10
JP5661744B2 (ja) 2015-01-28
US20120121638A1 (en) 2012-05-17
DK2248533T3 (da) 2014-02-10
EP2248533B1 (en) 2013-11-06
WO2010127784A1 (en) 2010-11-11
JP2012526059A (ja) 2012-10-25
US8741302B2 (en) 2014-06-03

Similar Documents

Publication Publication Date Title
IL254600A0 (en) pcsk9 vaccine
SG184289A1 (en) Novel peptides and methods for their preparation and use
IL215430A0 (en) Methods and compositions for immunization against virus
IL222027A (en) Peptides and their use
PL2588491T3 (pl) Nowy peptyd i jego zastosowanie
EP2480578A4 (en) MODIFICATION OF POLYPEPTIDE
IL229926A (en) Neil3 peptides and vaccines including the same
IL214257A0 (en) Peptides for vaccine
PL2248533T3 (pl) Polipeptyd pochodzący od enterokoka i jego zastosowanie do szczepienia
PL2464656T3 (pl) Nowy peptyd i jego zastosowanie
IL216199A (en) A peptide containing the sequence ednimvtfrnqasr
IL214762A0 (en) Modifications of cupredoxin derives peptides and methods of use thereof
IL216211A0 (en) Cdc45l peptides and vaccines including the same
EP2430039A4 (en) TTK-PEPTIDES AND VACCINES CONTAINING THEM
ZA201201387B (en) Bovine herpesvirus vaccine
IL214453A0 (en) Vangli peptides and vaccines including the same
GB0905790D0 (en) Novel polypeptides and use thereof
IL220146A0 (en) Tmem22 peptides and vaccines including the same
IL215268A0 (en) C6orf167 peptides and vaccines containing the same
GB0917685D0 (en) Antigenic polypeptide
PT2566506T (pt) Composição de vacina para a prevenção ou tratamento de leishmanioses
GB0917871D0 (en) Peptides for vaccine
GB0901928D0 (en) Peptides for vaccine
GB0902345D0 (en) Peptides for vaccine
GB0902344D0 (en) Peptides for vaccine